Bio-IT World July 16, 2024
Deborah Borfitz

Artificial intelligence (AI) is the new frontier in biomedical research, with large language models changing the way science is done from writing code and brainstorming research ideas to helping do research and conducting literature reviews. In some of its latest applications, generative AI has been used in designing molecules with insights produced at a scale and speed not possible with traditional deep learning methods alone, according to Marinka Zitnik, Ph.D., assistant professor of biomedical informatics at Harvard Medical School.

The potential of AI to aid in the development of new drugs to cure disease is enormous given the size of the chemical universe (1060 chemical compounds) relative to the tiny fraction (105) that has been synthesized...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Technology, Trends
New 'how-to guide' for future rapid vaccine development
Infographic: R&D Spending Growth of Top Pharma Companies
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Adoption Of Model-Informed Drug Development Can Improve Pharma ROI

Share This Article